technolog media telecommun contactless payment empir state mind
global pharmaceut investor day highlight sales-driven leverag estimate new vaccin oppt
medic suppli devic paclitaxel panel day benefit ptx-coat devic continu outweigh risk
got hemophilia
page analyst certif import disclosur
media internet commun daili daili shop announc five-year fulfil center invest expand
revenu opportun news fb crypto hear senat bank committe schedul juli releas film
publish june
messag come polit upheav uk recent ndr believ continu screen attract util albeit one
intract overhang brexit see ofgem nation headwind investor forecast extern like
brexit-associ currenc volatil remain difficult gain comfort around still pound near all-tim low labour closer down
get paid wait upsid bad proposit either view remain neutral continu look entri point brexit
becom visibl rais pt
reduc pt
publish june
messag ar respons collaps ngl price abroad main topic call expect
discuss initi reduc well oper cost although expect chang compound-annual-growth-rate believ may review ngl
price remain challeng year-end continu view ar intern exposur differenti factor remain buy rate reduc
price target reflect updat analysi
publish june
page analyst certif import disclosur
messag seven month amin maredia departur name groceri veteran sinclair ceo effect june expect
hire extern ceo drive chang interim ceo/cfo brad lukow leav compani howev jim nielsen return
point well-respect chip molloy take cfo rein interim basi may put end unusu amount
senior manag turnov experienc sinc ipo remain neutral-r larg on-going n-t cost-rel profit pressur though
increasingli discount exhibit
 buy domin leadership continu
publish june
messag opinion initi guid conserv prudent given uncertain consum demand macro headwind continu
recogn darden best class casual diner expect og incent calendar normal cheddar oper stabil addit
focu off-premis opportun across brand fuel compstore support bottom line profit growth reiter pt buy rate
base manag superior execut total sharehold return focu
vaccin oppt biggest differ vs model
publish june
messag mrk investor day june first sinc showcas compani broader management team ahead like first
meaning management transit nearli decad oper well posit deliv sustain sale earn growth januvia
patent expir beyond driven indic expans keytruda lynparza w/ azn lenvima w/ esali continu global
growth gardasil expand vaccin pipelin led pneumococc vaccin sustain above-market anim health growth
intern pipelin led gefapix chronic cough hiv bolster recent acquisit futur bolt-on/licens deal
flattish oper cost structur facilit leverag includ beyond balanc today present stock
move project suggest underappreci growth asset resid vaccin portfolio
dealmak work
publish june
messag recent regulatori field trip help frame debat t-mobile/sprint investor eagerli await news propos
transact recent wsj report indic emerg potenti partner asset regul seek way maintain four-
player wireless industri could pois scoop spectrum asset prepaid sub possibl asset divestitur report bloomberg
page analyst certif import disclosur
among other also emerg directv could talk combin busi could provid exit strategi
satellit tv busi
publish june
messag nike sourcing/revenu exposur remain epicent on-going geopolit uncertainti /china howev
amidst global geopolit dynam continu deliv sustain growth region month recalibr plan attack
investor day anchor consum direct offens continu believ laid strong foundat transform
investments/distinct focu innov believ underli busi remain strong cogniz fx remain buy-rat
publish june
messag close file issu press releas reaffirm full-year outlook three-year financi roadmap
plan annual dividend outlin progress restructuring/cost save action maintain estim
encourag updat increas convict secur dividend provid addit clariti current expect yield
reiter buy rate detail look outlook compani pleas find initi
buy takeaway meet management highlight
confid ripretinib clinic profil opportun
publish june
messag host lunch meet ceo steve hoerter cfo tucker kelli cso flynn head ir jen robinson discuss recent
highlight near-term expect across pipelin takeaway invictu remain on-track readout management
believ month benefit placebo would clinic meaning ripretinib safeti profil could key differenti factor vs competitor
avapritinib potenti ripretinib launch plan intern excit ulk inhibitor target autophagi
page analyst certif import disclosur
ndr tale market valu
publish june
messag follow ndr management continu see one deep valu coverag univers especi versu ga
comp meet help solidifi buy rate firm view compani ep growth support etg sjg rate
case double-digit rate base growth roe lag improvement/high equiti layer iip program penneast contribut less volatil non-util
earn uneconom contract shed
commerci zanubrutinib tislelizumab
publish june
messag morn bgne review result number clinic studi zanubrutinib tislelizumab present recent medic
meet provid brief corpor updat matur clinic dataset variou zanubrutinib trial blood cancer continu support bgne
view potenti differenti current approv btk inhibitor accord management re-acquisit tislelizumab right open rang
strateg option bgne commerci asset global expand springwork collabor facilit dev new braf inhibitor
kr buy clear lower bar lot noisen-t
reaction depend call
publish june
messag investor expect kr print worsen quarter wore especi neg commentari recent weeksagainst
backdrop perform bad anticip non-fuel comp rose non-fuel gross margin eros improv sequenti
full-year ebit target maintain said oper result still noisi much work remain respect stabil non-fuel
ebit aforement target appear optimist share indic morn lot hing call remain
page analyst certif import disclosur
axgt axov partner yposkesi viral vector
publish june
messag announc collabor european yposkesi genethon spin-out expertis cgmp grade viral
vector manufactur process develop technolog transfer qc/qa initi focu aav-bas gene therapi pipelin recal
agreement place principl view increment posit believ partnership allow gene
therapi scale-up effici maintain buy
conserv guidanc expect
publish june
messag anticip manag initi ep guidanc conserv consensu
highlight consist beat rais histori last year upsid year initi guidanc midpoint
compstore og fell short consensu outlook first time quarter ebitda met expect expans y/i reflect
 market control well stabl rm essenti rm labor delev y/i amid msd wage inflat
contactless payment empir state mind
publish june
messag last year visa mastercard highlight contactless payment area signific potenti gener new card-
base payment volum contactless recent launch select nyc public transit locat decid deep dive base
experi test technolog subway turnstil monitor initi adopt rate three differ nyc subway station interview
earli adopt contactless subway rider analyz histor data contactless major economi launch similar
condit current occur within come away highli posit technolog believ becom signific driver
new card-bas volum ultim believ contactless payment add increment payment volum
card network total revenu signific given network size
paclitaxel panel day benefit ptx-coat devic continu outweigh risk
page analyst certif import disclosur
publish june
messag fda held day circulatori devic advisori panel thursday discuss potenti late mortal signal paclitaxel-
coat peripher vascular balloons/st see day takeaway despit panel unanim conclud late mortal signal present
data ptx-coat devic also overwhelmingli favor keep product market recommend label chang
enhanc post-market surveil lieu sever regulatori action line think come day view
set tabl rebound ptx-coat devic util
publish june
messag manag system increasingli attract attent larg privat transact make headlin public ps begin
call valu system investor found sever smid cap permian ps begun build water infrastructur larger
degre oper footprint would requir suggest us potenti opportun either expand water manag system beyond
in-hous volum even monet asset
got hemophilia
publish june
messag given recent headlin get lot question pharma compani hemophilia may
look gene therapi asset put togeth overview hemophilia landscap categor non-gen therapi hem-a hem-b
pipelin gene therapi compani without announc gene therapi program includ csl-asx novo b-cse bayn-etr san
takeda late-stag program san appear focus lv approach hemophilia gene therapi program collab
oxb-lon
daili shop announc five-year fulfil center invest expand revenu opportun news fb
crypto hear senat bank committe schedul juli releas film slate includ new
page analyst certif import disclosur
publish june
shop unit deliv invest build fulfil network expand revenu opportun link wong highlight shopifi announc
fulfil center anticip posit investor sentiment given increment revenu opportun potenti adopt larg custom
publish june
guggenheim ndr schedul pleas scroll
duk/nc/polici nc modern legisl pass financ committe modif
fe ohio scotu rule dmr order remov rider
governor ducey spar
pa governor wolf propos move pennsylvania rggi
epa final afford clean rule post replac clean power
ale/lnt/wec critic wi atc project focu storag altern hear
bipartisan pfoa/pfo legisl introduc senat
polici world largest uranium produc warn specter tariff
polici new report warn carbon free loss nuclear retir
puct deni request strike testimoni staff motion declassifi discoveri respons
page analyst certif import disclosur
inc
primari analyst jake fuller
page analyst certif import disclosur
smart final store inc
primari analyst glen santangelo
page analyst certif import disclosur
explor product
page analyst certif import disclosur
